Janus Henderson Group’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $318K | Hold |
33,756
| – | – | ﹤0.01% | 2189 |
|
|
2025
Q4 | $419K | Hold |
33,756
| – | – | ﹤0.01% | 2083 |
|
|
2025
Q3 | $484K | Hold |
33,756
| – | – | ﹤0.01% | 2015 |
|
|
2025
Q2 | $414K | Hold |
33,756
| – | – | ﹤0.01% | 2035 |
|
|
2025
Q1 | $731K | Hold |
33,756
| – | – | ﹤0.01% | 1772 |
|
|
2024
Q4 | $766K | Hold |
33,756
| – | – | ﹤0.01% | 1817 |
|
|
2024
Q3 | $613K | Hold |
33,756
| – | – | ﹤0.01% | 1932 |
|
|
2024
Q2 | $982K | Sell |
33,756
-349
| -1% | -$10.3K | ﹤0.01% | 1629 |
|
|
2024
Q1 | $1.21M | Hold |
34,105
| – | – | ﹤0.01% | 1543 |
|
|
2023
Q4 | $1.49M | Sell |
34,105
-63
| -0.2% | -$2.48K | ﹤0.01% | 1410 |
|
|
2023
Q3 | $1.31M | Sell |
34,168
-8
| -0% | -$337 | ﹤0.01% | 1419 |
|
|
2023
Q2 | $1.41M | Sell |
34,176
-1,669,911
| -98% | -$80.4M | ﹤0.01% | 1431 |
|
|
2023
Q1 | $97.8M | Sell |
1,704,087
-933,972
| -35% | -$52.6M | 0.06% | 252 |
|
|
2022
Q4 | $148M | Sell |
2,638,059
-3,707,017
| -58% | -$189M | 0.11% | 193 |
|
|
2022
Q3 | $269M | Buy |
6,345,076
+3,064,928
| +93% | +$157M | 0.1% | 199 |
|
|
2022
Q2 | $177M | Sell |
3,280,148
-2,744
| -0.1% | -$165K | 0.12% | 185 |
|
|
2022
Q1 | $211M | Sell |
3,282,892
-465,392
| -12% | -$30.6M | 0.1% | 199 |
|
|
2021
Q4 | $251M | Sell |
3,748,284
-395,441
| -10% | -$26.8M | 0.1% | 199 |
|
|
2021
Q3 | $284M | Sell |
4,143,725
-499,344
| -11% | -$35.3M | 0.12% | 185 |
|
|
2021
Q2 | $317M | Sell |
4,643,069
-14,094
| -0.3% | -$997K | 0.14% | 178 |
|
|
2021
Q1 | $322M | Buy |
4,657,163
+35,000
| +0.8% | +$2.37M | 0.15% | 164 |
|
|
2020
Q4 | $300M | Buy |
4,622,163
+572,291
| +14% | +$30.8M | 0.14% | 163 |
|
|
2020
Q3 | $191M | Sell |
4,049,872
-145,314
| -3% | -$6.91M | 0.1% | 210 |
|
|
2020
Q2 | $197M | Sell |
4,195,186
-110,740
| -3% | -$5.44M | 0.11% | 194 |
|
|
2020
Q1 | $192M | Sell |
4,305,926
-6,921
| -0.2% | -$363K | 0.13% | 168 |
|
|
2019
Q4 | $251M | Buy |
4,312,847
+1,086,385
| +34% | +$64.7M | 0.13% | 184 |
|
|
2019
Q3 | $194M | Sell |
3,226,462
-22,408
| -0.7% | -$1.34M | 0.11% | 210 |
|
|
2019
Q2 | $181M | Buy |
3,248,870
+375,546
| +13% | +$19.3M | 0.1% | 234 |
|
|
2019
Q1 | $160M | Buy |
2,873,324
+688,761
| +32% | +$35.1M | 0.09% | 267 |
|
|
2018
Q4 | $98.5M | Buy |
2,184,563
+175,432
| +9% | +$9.63M | 0.06% | 348 |
|
|
2018
Q3 | $132M | Buy |
2,009,131
+42,790
| +2% | +$2.66M | 0.07% | 325 |
|
|
2018
Q2 | $127M | Buy |
1,966,341
+365,254
| +23% | +$22.6M | 0.07% | 331 |
|
|
2018
Q1 | $88.6M | Sell |
1,601,087
-2,665
| -0.2% | -$140K | 0.05% | 397 |
|
|
2017
Q4 | $76.8M | Sell |
1,603,752
-431,536
| -21% | -$21.1M | 0.05% | 429 |
|
|
2017
Q3 | $103M | Sell |
2,035,288
-20,625
| -1% | -$1.06M | 0.07% | 355 |
|
|
2017
Q2 | $112M | Buy |
+2,055,913
| New | +$98.2M | 0.08% | 325 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
Janus Henderson Group's IART Position: Q1 2026 in Review
Janus Henderson Group held its Integra LifeSciences (IART) position steady in Q1 2026 at 33,756 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #2189.
Janus Henderson Group first reported a position in IART in Q2 2017 and has held it in 36 quarters since. The position peaked at $322M in Q1 2021. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Janus Henderson Group held 33,756 shares of Integra LifeSciences worth $318K as of Q1 2026.
- Janus Henderson Group left its Integra LifeSciences share count unchanged in Q1 2026.
- Integra LifeSciences made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2189 holding.
- Janus Henderson Group first reported a position in Integra LifeSciences in Q2 2017 and has held it in 36 quarters since.
- Janus Henderson Group's Integra LifeSciences position peaked at $322M in Q1 2021.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.